Dr Martens PLC
LSE:DOCS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Dr Martens PLC
LSE:DOCS
|
UK |
|
Brainstorm Cell Therapeutics Inc
NASDAQ:BCLI
|
US |
|
American Water Works Company Inc
NYSE:AWK
|
US |
|
N
|
Nexters Inc
NASDAQ:GDEV
|
VG |
|
Fastenal Co
NASDAQ:FAST
|
US |
|
K
|
Ksolves India Ltd
NSE:KSOLVES
|
IN |
|
R
|
Rostelekom PAO
MOEX:RTKM
|
RU |
|
Sunoco LP
NYSE:SUN
|
US |
|
Confinvest FL SpA
MIL:CFV
|
IT |
|
G
|
Grenergy Renovables SA
MAD:GRE
|
ES |
Wall Street
Price Targets
DOCS Price Targets Summary
Dr Martens PLC
According to Wall Street analysts, the average 1-year price target for
DOCS
is 102.15 GBX
with a low forecast of 76.76 GBX and a high forecast of 148.05 GBX.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is DOCS's stock price target?
Price Target
102.15
GBX
According to Wall Street analysts, the average 1-year price target for
DOCS
is 102.15 GBX
with a low forecast of 76.76 GBX and a high forecast of 148.05 GBX.
What is Dr Martens PLC's Revenue forecast?
Projected CAGR
4%
For the last 6 years the
compound annual growth rate for
Dr Martens PLC's revenue is
10%.
The projected
CAGR
for the next 4 years is
4%.
What is Dr Martens PLC's Operating Income forecast?
Projected CAGR
15%
For the last 6 years the
compound annual growth rate for
Dr Martens PLC's operating income is
-1%.
The projected
CAGR
for the next 4 years is
15%.
What is Dr Martens PLC's Net Income forecast?
Projected CAGR
143%
For the last 6 years the
compound annual growth rate for
Dr Martens PLC's net income is
-20%.
The projected
CAGR
for the next 3 years is
143%.
